Delivery Order SPE2DB25D3003-SPE2DB25FPXBN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $10,748.99, is scheduled for completion by September 2, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a non-set-aside basis through competitive procurement procedures, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $3,439.80. This non-set-aside delivery order will be completed by August 5, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical supplier supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Progesterone 200 mg capsules in quantities of 30 units. This firm fixed-price delivery order, valued at $7,627.49, represents a non-competitive set-aside award and is scheduled for completion by August 6, 2025. The pharmaceutical product will be delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Department's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This firm fixed-price delivery order, valued at $18,213.07, represents a competitively awarded non-set-aside procurement with an ultimate completion date of August 18, 2025. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Progesterone 200 mg capsules (100 count) with a ceiling value of $4,508.52. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside contract vehicle, with an ultimate completion date of August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Progesterone 100 mg capsules (100-count units) with a ceiling value of $30,912.13. This firm fixed-price delivery order, which is expected to be completed by August 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 100 mg capsules (100-count units) on August 20, 2025, with a ceiling value of $4,312.01 and a firm fixed price structure. This non-set-aside delivery order is expected to be completed by August 21, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement to support federal medical supply needs, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Progesterone 200 mg capsules (30-count) with a contract ceiling value of $1,858.98. This firm fixed-price delivery order is scheduled for ultimate completion by August 20, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a contract ceiling value of $7,427.51. This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, represents a competitively awarded, non-set-aside contract executed through AmerisourceBergen's existing pharmaceutical supply vehicle with the federal government. The product will be delivered...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXBNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Progesterone 200 mg capsules in quantities of 100 units. This competitive award, valued at $40,514.82 with a firm fixed price structure, is scheduled for completion by September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating competition among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp serves military and veteran healthcare systems through the Defense Health Agency and related government medical supply chains. The company's extensive portfolio includes brand-name and generic pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic areas, positioning it as a primary source for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.5k | 8/29/25 |